OCUL Stock Analysis: Buy, Sell, or Hold?
OCUL - Ocular Therapeutix, Inc.
$11.08
-0.01 (-0.09%)
▼
5d:
+10.36%
30d:
+28.54%
90d:
+34.79%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Aug 12, 2026 at $10.23 · last confirmed Aug 21, 2026
Strength: 8.5/10
Get Alerted When OCUL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: OCUL shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: OCUL shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: OCUL is currently trading at $11.08, which is considered extended relative to its 30-day fair value range of $8.41 to $10.36.
Technical Outlook: Technically, OCUL is in a strong uptrend. Immediate support is located at $9.04, while resistance sits at $11.74.
Market Sentiment: OCUL scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $27.09 (+144.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OCUL is in a strong uptrend. Immediate support is located at $9.04, while resistance sits at $11.74.
Market Sentiment: OCUL scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $27.09 (+144.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$8.41 -
$10.36
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
Protect Your Profits
Holding OCUL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+6.9% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 144.5% below Wall St target ($27.09)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$8.41 -
$10.36
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.04
Resistance Level
$11.74
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.62
Wall Street Target
$27.09
(+144.5%)
Revenue Growth (YoY)
0.1%
Share & Embed Analysis
Last updated: August 23, 2026 5:05 AM ET
Data refreshes hourly during market hours. Next update: 6:05 AM
Data refreshes hourly during market hours. Next update: 6:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OCUL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$372 | 42 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 27 SELL |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$563 | 30 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 51 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
Advanced OCUL Option Strategies
Professional options setups generated by AI based on today's OCUL price and gamma walls.
